aThe Ginkgo biloba leaf extract used in the manufacture of this medicine must comply with the requirement of Identification Test B of the monographPowdered Ginkgo Extract in the United States Pharmacopeia 32 - National Formulary 27 (USP32-NF27). This condition does not apply to powdered ordried ...
Community herbal monograph on Ginkgo biloba L., folium EMA/HMPC/321097/2012 Page 7/8 5.2. Pharmacokinetic properties Well-established use Following oral administration (as solution) of 120 mg of the Ginkgo extract, the mean absolute bioavailability has been shown in humans for the terpene ...